| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 37 | 2024 | 997 | 5.170 |
Why?
|
| Anesthesia, Conduction | 15 | 2024 | 262 | 3.740 |
Why?
|
| Nerve Block | 17 | 2024 | 706 | 3.190 |
Why?
|
| Pain, Postoperative | 22 | 2024 | 1740 | 3.060 |
Why?
|
| Lidocaine | 14 | 2024 | 538 | 3.030 |
Why?
|
| Diabetic Neuropathies | 8 | 2018 | 405 | 2.560 |
Why?
|
| Anesthesia, Epidural | 7 | 2021 | 233 | 2.480 |
Why?
|
| Analgesia | 8 | 2022 | 461 | 2.040 |
Why?
|
| Anesthesia, Spinal | 6 | 2023 | 280 | 2.020 |
Why?
|
| Analgesia, Epidural | 10 | 2019 | 332 | 1.890 |
Why?
|
| Sciatic Nerve | 11 | 2024 | 617 | 1.570 |
Why?
|
| Amides | 5 | 2016 | 449 | 1.370 |
Why?
|
| Anesthesiology | 7 | 2022 | 1120 | 1.300 |
Why?
|
| Perioperative Period | 4 | 2020 | 250 | 1.240 |
Why?
|
| Anesthesia | 7 | 2022 | 1595 | 1.230 |
Why?
|
| Norepinephrine | 2 | 2021 | 897 | 1.210 |
Why?
|
| Phantom Limb | 3 | 2023 | 98 | 1.190 |
Why?
|
| Ganglia, Spinal | 10 | 2012 | 526 | 1.170 |
Why?
|
| Anesthesia, Obstetrical | 4 | 2017 | 233 | 1.130 |
Why?
|
| Peripheral Nerves | 7 | 2024 | 479 | 1.060 |
Why?
|
| Anesthesia, Local | 4 | 2023 | 277 | 1.020 |
Why?
|
| Bupivacaine | 10 | 2019 | 412 | 0.970 |
Why?
|
| Analgesics | 11 | 2024 | 1070 | 0.860 |
Why?
|
| Ligamentum Flavum | 4 | 2016 | 20 | 0.840 |
Why?
|
| Amputees | 1 | 2023 | 91 | 0.820 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2012 | 687 | 0.810 |
Why?
|
| Analgesics, Opioid | 11 | 2024 | 3808 | 0.810 |
Why?
|
| Colorectal Surgery | 1 | 2024 | 122 | 0.790 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2016 | 301 | 0.750 |
Why?
|
| Abscess | 3 | 2021 | 606 | 0.740 |
Why?
|
| Perioperative Care | 4 | 2024 | 1036 | 0.720 |
Why?
|
| Hematoma, Epidural, Spinal | 2 | 2018 | 37 | 0.710 |
Why?
|
| Neurons, Afferent | 6 | 2008 | 498 | 0.690 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2021 | 53 | 0.690 |
Why?
|
| Analgesics, Non-Narcotic | 5 | 2019 | 370 | 0.690 |
Why?
|
| Hematoma | 3 | 2021 | 767 | 0.680 |
Why?
|
| Amitriptyline | 4 | 2007 | 112 | 0.660 |
Why?
|
| Analgesia, Obstetrical | 2 | 2018 | 169 | 0.660 |
Why?
|
| Acetaminophen | 6 | 2024 | 555 | 0.650 |
Why?
|
| Meningitis | 1 | 2020 | 217 | 0.630 |
Why?
|
| Atracurium | 5 | 2005 | 51 | 0.620 |
Why?
|
| Pain Measurement | 12 | 2021 | 3551 | 0.610 |
Why?
|
| Injections | 2 | 2018 | 831 | 0.540 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2013 | 710 | 0.520 |
Why?
|
| Pressure | 2 | 2018 | 1154 | 0.510 |
Why?
|
| Thoracic Vertebrae | 3 | 2005 | 597 | 0.500 |
Why?
|
| Exhalation | 3 | 2005 | 181 | 0.490 |
Why?
|
| Risk Management | 1 | 2018 | 558 | 0.490 |
Why?
|
| Laparoscopy | 2 | 2024 | 2036 | 0.470 |
Why?
|
| Anesthesia Recovery Period | 1 | 2015 | 155 | 0.470 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2018 | 10766 | 0.450 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2021 | 1413 | 0.450 |
Why?
|
| Evidence-Based Medicine | 3 | 2024 | 3688 | 0.450 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 1166 | 0.440 |
Why?
|
| Orthopedics | 1 | 2022 | 898 | 0.440 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 145 | 0.430 |
Why?
|
| Ondansetron | 1 | 2013 | 95 | 0.420 |
Why?
|
| Orthopedic Procedures | 2 | 2022 | 1265 | 0.420 |
Why?
|
| Membrane Potentials | 5 | 2008 | 1090 | 0.420 |
Why?
|
| Laryngeal Masks | 5 | 2004 | 103 | 0.410 |
Why?
|
| Cadaver | 9 | 2024 | 1358 | 0.410 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1119 | 0.400 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 942 | 0.400 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2022 | 1393 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 2691 | 0.380 |
Why?
|
| Rats | 18 | 2018 | 23741 | 0.370 |
Why?
|
| DNA Methylation | 3 | 2015 | 4399 | 0.360 |
Why?
|
| Humans | 113 | 2024 | 761596 | 0.360 |
Why?
|
| Fentanyl | 4 | 2017 | 434 | 0.350 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 4 | 2005 | 143 | 0.350 |
Why?
|
| Butadienes | 3 | 2008 | 107 | 0.340 |
Why?
|
| Mass Spectrometry | 8 | 2008 | 2192 | 0.330 |
Why?
|
| Anesthesia, General | 4 | 2017 | 1174 | 0.330 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 1182 | 0.320 |
Why?
|
| Lower Extremity | 4 | 2024 | 1202 | 0.310 |
Why?
|
| Netherlands | 5 | 2020 | 2221 | 0.300 |
Why?
|
| Axons | 2 | 2007 | 1674 | 0.300 |
Why?
|
| Anesthetics, Inhalation | 6 | 2003 | 574 | 0.300 |
Why?
|
| Organic Chemicals | 2 | 2008 | 210 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1667 | 0.300 |
Why?
|
| Breath Tests | 5 | 2008 | 299 | 0.290 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1403 | 0.290 |
Why?
|
| Imidazoles | 3 | 2012 | 1180 | 0.290 |
Why?
|
| Cervical Vertebrae | 2 | 2004 | 980 | 0.290 |
Why?
|
| Acetonitriles | 2 | 2005 | 54 | 0.290 |
Why?
|
| Neurons | 5 | 2012 | 9463 | 0.280 |
Why?
|
| Abdomen | 3 | 2019 | 1128 | 0.280 |
Why?
|
| Pneumonia, Aspiration | 2 | 2004 | 146 | 0.280 |
Why?
|
| Postoperative Complications | 5 | 2020 | 15633 | 0.280 |
Why?
|
| Pentanes | 2 | 2003 | 5 | 0.270 |
Why?
|
| Hemiterpenes | 2 | 2003 | 18 | 0.270 |
Why?
|
| Hypotension | 1 | 2012 | 879 | 0.270 |
Why?
|
| Isoquinolines | 2 | 2005 | 352 | 0.260 |
Why?
|
| Sulfones | 2 | 2005 | 448 | 0.250 |
Why?
|
| Ketamine | 3 | 2018 | 519 | 0.250 |
Why?
|
| Diclofenac | 2 | 2017 | 68 | 0.250 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 4915 | 0.250 |
Why?
|
| Subclavian Vein | 1 | 2005 | 57 | 0.250 |
Why?
|
| Electric Stimulation | 3 | 2017 | 1736 | 0.250 |
Why?
|
| Cesarean Section | 2 | 2012 | 1398 | 0.240 |
Why?
|
| Superior Cervical Ganglion | 1 | 2004 | 33 | 0.240 |
Why?
|
| Acrylates | 2 | 2004 | 78 | 0.240 |
Why?
|
| Hydrofluoric Acid | 1 | 2004 | 13 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 3801 | 0.240 |
Why?
|
| Xerophthalmia | 1 | 2004 | 12 | 0.230 |
Why?
|
| Enzyme Inhibitors | 4 | 2012 | 3713 | 0.230 |
Why?
|
| Pantothenic Acid | 1 | 2004 | 17 | 0.230 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2004 | 129 | 0.230 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2015 | 58 | 0.230 |
Why?
|
| Prader-Willi Syndrome | 1 | 2004 | 78 | 0.220 |
Why?
|
| Wound Healing | 1 | 2015 | 2805 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 3 | 2005 | 908 | 0.220 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.220 |
Why?
|
| Oral Surgical Procedures | 1 | 2005 | 166 | 0.220 |
Why?
|
| Rats, Zucker | 2 | 2014 | 131 | 0.220 |
Why?
|
| Procaine | 2 | 2014 | 60 | 0.220 |
Why?
|
| Caspases | 3 | 2016 | 879 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2019 | 2273 | 0.220 |
Why?
|
| Burns, Chemical | 1 | 2004 | 123 | 0.220 |
Why?
|
| Lactones | 1 | 2005 | 317 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 1246 | 0.210 |
Why?
|
| Cell Survival | 5 | 2014 | 5791 | 0.210 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2017 | 116 | 0.210 |
Why?
|
| Halothane | 1 | 2003 | 200 | 0.210 |
Why?
|
| Cellulose | 1 | 2003 | 118 | 0.210 |
Why?
|
| Thigh | 1 | 2024 | 241 | 0.210 |
Why?
|
| Dwarfism | 1 | 2003 | 138 | 0.210 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 136 | 0.210 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 598 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2018 | 3429 | 0.200 |
Why?
|
| Radial Artery | 1 | 2004 | 187 | 0.200 |
Why?
|
| Upper Extremity | 2 | 2024 | 658 | 0.200 |
Why?
|
| Inflammation | 4 | 2015 | 10774 | 0.200 |
Why?
|
| Delirium | 1 | 2013 | 1668 | 0.190 |
Why?
|
| Pyridines | 3 | 2012 | 2875 | 0.190 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 313 | 0.190 |
Why?
|
| Action Potentials | 4 | 2015 | 1834 | 0.190 |
Why?
|
| Electrocardiography | 1 | 2014 | 6377 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2012 | 8181 | 0.180 |
Why?
|
| Female | 47 | 2024 | 392705 | 0.180 |
Why?
|
| Animals | 24 | 2018 | 168475 | 0.180 |
Why?
|
| Spinal Nerves | 3 | 2012 | 91 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
| Vitamin A | 1 | 2004 | 613 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2016 | 572 | 0.180 |
Why?
|
| Blood Patch, Epidural | 1 | 2021 | 57 | 0.180 |
Why?
|
| Calcium | 3 | 2008 | 5722 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2004 | 343 | 0.180 |
Why?
|
| Terrorism | 1 | 2003 | 211 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 526 | 0.170 |
Why?
|
| Apoptosis | 6 | 2012 | 9490 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2015 | 895 | 0.170 |
Why?
|
| Critical Care | 2 | 2021 | 2697 | 0.170 |
Why?
|
| Mastectomy | 2 | 2019 | 1822 | 0.170 |
Why?
|
| Eye | 1 | 2004 | 712 | 0.170 |
Why?
|
| Wounds and Injuries | 3 | 2017 | 2492 | 0.170 |
Why?
|
| Prisoners | 1 | 2003 | 314 | 0.170 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3980 | 0.170 |
Why?
|
| Needles | 2 | 2015 | 451 | 0.160 |
Why?
|
| Methyl Ethers | 5 | 2003 | 196 | 0.160 |
Why?
|
| Air Pollutants, Occupational | 4 | 2002 | 407 | 0.160 |
Why?
|
| Brachial Plexus | 1 | 2021 | 167 | 0.160 |
Why?
|
| Mass Screening | 3 | 2008 | 5429 | 0.160 |
Why?
|
| Efficiency | 1 | 2022 | 476 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2012 | 18966 | 0.160 |
Why?
|
| Respiratory Rate | 1 | 2019 | 176 | 0.150 |
Why?
|
| Vital Signs | 1 | 2019 | 144 | 0.150 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 21019 | 0.150 |
Why?
|
| Arm Injuries | 1 | 2019 | 156 | 0.150 |
Why?
|
| Pregnancy | 7 | 2021 | 29890 | 0.150 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2021 | 537 | 0.150 |
Why?
|
| Leg Injuries | 1 | 2019 | 179 | 0.150 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2217 | 0.150 |
Why?
|
| Saphenous Vein | 2 | 2021 | 516 | 0.150 |
Why?
|
| Lumbar Vertebrae | 2 | 2005 | 1879 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2014 | 1745 | 0.150 |
Why?
|
| Male | 43 | 2024 | 360846 | 0.140 |
Why?
|
| Sodium Channels | 3 | 2008 | 339 | 0.140 |
Why?
|
| Face | 1 | 2003 | 1026 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2024 | 1530 | 0.140 |
Why?
|
| Mepivacaine | 1 | 2016 | 8 | 0.140 |
Why?
|
| Time Factors | 11 | 2019 | 39969 | 0.140 |
Why?
|
| Neoplasms | 7 | 2021 | 22173 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3597 | 0.140 |
Why?
|
| Pain | 7 | 2021 | 5073 | 0.140 |
Why?
|
| Sufentanil | 1 | 2016 | 42 | 0.140 |
Why?
|
| Intubation, Intratracheal | 5 | 2004 | 1333 | 0.130 |
Why?
|
| Spine | 1 | 2003 | 1118 | 0.130 |
Why?
|
| Treatment Refusal | 1 | 2019 | 429 | 0.130 |
Why?
|
| Necrosis | 1 | 2020 | 1611 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1423 | 0.130 |
Why?
|
| Operating Rooms | 4 | 2003 | 789 | 0.130 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 741 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 441 | 0.130 |
Why?
|
| Abdominal Wall | 1 | 2017 | 166 | 0.130 |
Why?
|
| Catastrophization | 1 | 2019 | 348 | 0.130 |
Why?
|
| Consensus | 1 | 2024 | 3124 | 0.120 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2007 | 432 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 10212 | 0.120 |
Why?
|
| Adult | 30 | 2020 | 221210 | 0.120 |
Why?
|
| Platelet Count | 1 | 2017 | 781 | 0.120 |
Why?
|
| Lumbosacral Region | 1 | 2016 | 293 | 0.120 |
Why?
|
| Risk | 3 | 2017 | 9610 | 0.120 |
Why?
|
| Middle Aged | 27 | 2020 | 220921 | 0.110 |
Why?
|
| Dexmedetomidine | 1 | 2018 | 319 | 0.110 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2013 | 25 | 0.110 |
Why?
|
| Torsades de Pointes | 1 | 2014 | 78 | 0.110 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.110 |
Why?
|
| Anesthetics, General | 1 | 2015 | 151 | 0.110 |
Why?
|
| Neuromuscular Agents | 1 | 2015 | 147 | 0.110 |
Why?
|
| Drug Synergism | 2 | 2015 | 1757 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1796 | 0.110 |
Why?
|
| Catheterization | 1 | 2019 | 1428 | 0.110 |
Why?
|
| Chi-Square Distribution | 4 | 2019 | 3415 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2004 | 2598 | 0.110 |
Why?
|
| Treatment Failure | 3 | 2022 | 2643 | 0.110 |
Why?
|
| Neopterin | 2 | 2003 | 56 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 728 | 0.110 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 58984 | 0.110 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 307 | 0.100 |
Why?
|
| Azacitidine | 1 | 2014 | 336 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 464 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 476 | 0.100 |
Why?
|
| Treatment Outcome | 12 | 2021 | 64685 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 2017 | 607 | 0.100 |
Why?
|
| Magnesium | 1 | 2015 | 804 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5672 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 411 | 0.100 |
Why?
|
| Musculoskeletal System | 1 | 2013 | 188 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2019 | 1948 | 0.090 |
Why?
|
| Models, Animal | 2 | 2015 | 2112 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2021 | 5971 | 0.090 |
Why?
|
| Hyperalgesia | 1 | 2015 | 532 | 0.090 |
Why?
|
| Cell Count | 2 | 2012 | 1835 | 0.090 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2019 | 988 | 0.090 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 646 | 0.090 |
Why?
|
| Smoking | 2 | 2005 | 9053 | 0.090 |
Why?
|
| Aged | 18 | 2020 | 169310 | 0.090 |
Why?
|
| Double-Blind Method | 4 | 2017 | 12341 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2014 | 467 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2020 | 41495 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1386 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 4 | 2021 | 1496 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2012 | 578 | 0.080 |
Why?
|
| Behavior, Animal | 3 | 2012 | 1878 | 0.080 |
Why?
|
| Epidural Space | 2 | 2016 | 122 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2012 | 326 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2012 | 930 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 750 | 0.080 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2011 | 127 | 0.080 |
Why?
|
| Triage | 1 | 2016 | 986 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 1 | 2015 | 823 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
| Cell Size | 2 | 2008 | 624 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2016 | 8633 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2018 | 23447 | 0.080 |
Why?
|
| Anthracenes | 1 | 2008 | 83 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1967 | 0.080 |
Why?
|
| Lumbosacral Plexus | 1 | 2008 | 51 | 0.080 |
Why?
|
| Obturator Nerve | 2 | 2023 | 11 | 0.080 |
Why?
|
| Edetic Acid | 1 | 2008 | 276 | 0.070 |
Why?
|
| Occupational Exposure | 3 | 2003 | 1813 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 513 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2811 | 0.070 |
Why?
|
| Psoas Muscles | 1 | 2008 | 66 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2021 | 80647 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1062 | 0.070 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 2164 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2005 | 517 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2010 | 971 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2010 | 590 | 0.070 |
Why?
|
| Cadmium | 1 | 2008 | 214 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2007 | 73 | 0.070 |
Why?
|
| Data Collection | 3 | 2005 | 3322 | 0.070 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 7879 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2015 | 1108 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2008 | 387 | 0.070 |
Why?
|
| Skin | 1 | 2020 | 4484 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4347 | 0.070 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2006 | 68 | 0.070 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2006 | 93 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6131 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 4853 | 0.070 |
Why?
|
| PC12 Cells | 1 | 2006 | 317 | 0.070 |
Why?
|
| Infusions, Parenteral | 2 | 2017 | 397 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1574 | 0.070 |
Why?
|
| Europe | 1 | 2013 | 3420 | 0.070 |
Why?
|
| Enzyme Precursors | 1 | 2006 | 170 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1902 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2020 | 23996 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2008 | 562 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2426 | 0.060 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2006 | 173 | 0.060 |
Why?
|
| Hyperglycemia | 2 | 2018 | 1376 | 0.060 |
Why?
|
| Swine | 1 | 2015 | 5915 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2006 | 240 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2008 | 1262 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 1682 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8002 | 0.060 |
Why?
|
| Visual Perception | 1 | 2013 | 1389 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 427 | 0.060 |
Why?
|
| Anesthesia, Inhalation | 2 | 2004 | 220 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 694 | 0.060 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 176 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 7968 | 0.060 |
Why?
|
| HELLP Syndrome | 1 | 2004 | 40 | 0.060 |
Why?
|
| Education, Continuing | 1 | 2005 | 114 | 0.060 |
Why?
|
| Ointments | 1 | 2004 | 58 | 0.060 |
Why?
|
| Catheters | 2 | 2019 | 427 | 0.060 |
Why?
|
| Nitrates | 1 | 2005 | 263 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2004 | 97 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2017 | 2242 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2018 | 6391 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 731 | 0.060 |
Why?
|
| Anesthetics, Intravenous | 2 | 2004 | 395 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3415 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2209 | 0.060 |
Why?
|
| Androstanols | 1 | 2003 | 45 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7391 | 0.060 |
Why?
|
| Trigeminal Ganglion | 1 | 2004 | 190 | 0.060 |
Why?
|
| Heart Septum | 1 | 2004 | 301 | 0.060 |
Why?
|
| Moscow | 1 | 2003 | 6 | 0.060 |
Why?
|
| Gastritis | 1 | 2005 | 199 | 0.060 |
Why?
|
| Body Weight | 1 | 2014 | 4618 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 330 | 0.050 |
Why?
|
| Punctures | 1 | 2004 | 366 | 0.050 |
Why?
|
| Intracranial Hypertension | 1 | 2005 | 193 | 0.050 |
Why?
|
| Nitriles | 1 | 2008 | 971 | 0.050 |
Why?
|
| Fascia | 1 | 2023 | 140 | 0.050 |
Why?
|
| Accidents, Occupational | 1 | 2004 | 249 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2019 | 54423 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 2850 | 0.050 |
Why?
|
| Aging | 3 | 2014 | 8710 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2005 | 377 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 282 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2005 | 388 | 0.050 |
Why?
|
| Cytosol | 1 | 2005 | 888 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2003 | 523 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 220 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2005 | 2079 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 12149 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6312 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 174 | 0.050 |
Why?
|
| Forearm | 1 | 2004 | 427 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2005 | 1638 | 0.050 |
Why?
|
| Toluidines | 1 | 2001 | 21 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2003 | 679 | 0.050 |
Why?
|
| Urologic Surgical Procedures | 1 | 2004 | 298 | 0.050 |
Why?
|
| Propofol | 2 | 2004 | 603 | 0.050 |
Why?
|
| Phenotype | 3 | 2008 | 16592 | 0.050 |
Why?
|
| Craniotomy | 1 | 2005 | 741 | 0.050 |
Why?
|
| Inhalation Exposure | 1 | 2003 | 432 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2021 | 245 | 0.040 |
Why?
|
| Postoperative Care | 2 | 2017 | 1468 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18255 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2004 | 579 | 0.040 |
Why?
|
| Neutrophils | 1 | 2013 | 3767 | 0.040 |
Why?
|
| Demography | 1 | 2005 | 1648 | 0.040 |
Why?
|
| Rhinoplasty | 1 | 2003 | 238 | 0.040 |
Why?
|
| Veins | 1 | 2004 | 768 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2021 | 162 | 0.040 |
Why?
|
| Nitric Oxide | 3 | 2005 | 2136 | 0.040 |
Why?
|
| Iceland | 1 | 2019 | 184 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1486 | 0.040 |
Why?
|
| Hospital Administration | 1 | 2003 | 353 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2922 | 0.040 |
Why?
|
| Infusions, Subcutaneous | 1 | 2019 | 43 | 0.040 |
Why?
|
| Young Adult | 6 | 2019 | 59260 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2005 | 2257 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 705 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2677 | 0.040 |
Why?
|
| Hand | 1 | 2004 | 903 | 0.040 |
Why?
|
| Hydrogels | 1 | 2004 | 720 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2004 | 42232 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2021 | 911 | 0.040 |
Why?
|
| Observer Variation | 1 | 2004 | 2606 | 0.040 |
Why?
|
| Peritoneum | 1 | 2019 | 225 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 16990 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 3267 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12794 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2008 | 8321 | 0.030 |
Why?
|
| Infusions, Intralesional | 1 | 2016 | 3 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2010 | 26202 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10451 | 0.030 |
Why?
|
| Drug Dosage Calculations | 1 | 2016 | 117 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 2016 | 50 | 0.030 |
Why?
|
| Peroneal Nerve | 1 | 2016 | 76 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8554 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 771 | 0.030 |
Why?
|
| Polymers | 1 | 2003 | 1616 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 141 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2002 | 1460 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3222 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 1457 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1492 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2005 | 3113 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2003 | 757 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2002 | 768 | 0.030 |
Why?
|
| Knee Joint | 1 | 2024 | 1676 | 0.030 |
Why?
|
| Laparotomy | 1 | 2017 | 457 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2016 | 441 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 377 | 0.030 |
Why?
|
| Ion Channels | 1 | 2019 | 1040 | 0.030 |
Why?
|
| Pain Perception | 1 | 2016 | 196 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2016 | 704 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 1462 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 2894 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2004 | 1469 | 0.030 |
Why?
|
| Models, Biological | 3 | 2008 | 9469 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2017 | 350 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2330 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 1924 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 2630 | 0.030 |
Why?
|
| Mitochondria | 1 | 2006 | 3624 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2016 | 464 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2004 | 2072 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1814 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2021 | 1489 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 4024 | 0.030 |
Why?
|
| United States | 1 | 2020 | 72340 | 0.030 |
Why?
|
| Patient Preference | 1 | 2019 | 927 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2016 | 683 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 15601 | 0.020 |
Why?
|
| Morphine | 1 | 2016 | 657 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3549 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1779 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2013 | 614 | 0.020 |
Why?
|
| Acute Disease | 2 | 2017 | 7237 | 0.020 |
Why?
|
| Superoxides | 1 | 2013 | 387 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2018 | 883 | 0.020 |
Why?
|
| Solubility | 1 | 2013 | 1091 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26129 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1440 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15843 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2013 | 963 | 0.020 |
Why?
|
| Volatilization | 1 | 2008 | 77 | 0.020 |
Why?
|
| Oocytes | 1 | 2013 | 1166 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 1987 | 0.020 |
Why?
|
| Femoral Nerve | 1 | 2008 | 42 | 0.020 |
Why?
|
| Doxepin | 1 | 2007 | 16 | 0.020 |
Why?
|
| Imipramine | 1 | 2007 | 98 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3076 | 0.020 |
Why?
|
| Oximes | 1 | 2008 | 303 | 0.020 |
Why?
|
| Xerostomia | 1 | 2007 | 94 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5368 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 4671 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3514 | 0.020 |
Why?
|
| Equipment Design | 2 | 2004 | 3511 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2007 | 173 | 0.020 |
Why?
|
| Proprioception | 1 | 2007 | 133 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3883 | 0.020 |
Why?
|
| Hydrogen Cyanide | 1 | 2005 | 4 | 0.020 |
Why?
|
| Research Design | 2 | 2015 | 6180 | 0.020 |
Why?
|
| Axotomy | 1 | 2005 | 71 | 0.020 |
Why?
|
| Bradycardia | 1 | 2007 | 299 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22176 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 2979 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39106 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 1379 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.020 |
Why?
|
| Ligation | 1 | 2005 | 448 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 237 | 0.010 |
Why?
|
| Capsaicin | 1 | 2005 | 231 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 426 | 0.010 |
Why?
|
| Potassium | 1 | 2008 | 1311 | 0.010 |
Why?
|
| Antidotes | 1 | 2005 | 138 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 20568 | 0.010 |
Why?
|
| Random Allocation | 1 | 2008 | 2395 | 0.010 |
Why?
|
| Recovery Room | 1 | 2003 | 34 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2004 | 5882 | 0.010 |
Why?
|
| Dogs | 1 | 2008 | 3839 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2008 | 858 | 0.010 |
Why?
|
| Sleep Stages | 1 | 2007 | 694 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3462 | 0.010 |
Why?
|
| Air | 1 | 2003 | 187 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 2004 | 164 | 0.010 |
Why?
|
| Biotransformation | 1 | 2003 | 166 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2007 | 757 | 0.010 |
Why?
|
| Operating Room Nursing | 1 | 2002 | 25 | 0.010 |
Why?
|
| Thoracic Injuries | 1 | 2005 | 288 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4062 | 0.010 |
Why?
|
| Elasticity | 1 | 2004 | 655 | 0.010 |
Why?
|
| Glutathione | 1 | 2005 | 583 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18399 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6426 | 0.010 |
Why?
|
| Postanesthesia Nursing | 1 | 2001 | 10 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2001 | 60 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 833 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1171 | 0.010 |
Why?
|
| Lung Injury | 1 | 2005 | 422 | 0.010 |
Why?
|
| Risk Factors | 2 | 2007 | 74213 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2004 | 426 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2004 | 947 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1833 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 20100 | 0.010 |
Why?
|
| Telephone | 1 | 2003 | 627 | 0.010 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2004 | 575 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1835 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2015 | 6635 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1668 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 88326 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 983 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9001 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9280 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2001 | 324 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2002 | 601 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 2002 | 639 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36426 | 0.010 |
Why?
|
| Isoflurane | 1 | 2001 | 384 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3810 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2005 | 1068 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2002 | 1560 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 1230 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3687 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4465 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4920 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4303 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4404 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2005 | 2054 | 0.010 |
Why?
|
| Child | 1 | 2021 | 80158 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2003 | 5493 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 4812 | 0.010 |
Why?
|
| Curriculum | 1 | 2003 | 3743 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 10002 | 0.000 |
Why?
|
| Algorithms | 1 | 2007 | 14033 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15266 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15502 | 0.000 |
Why?
|
| Infant | 1 | 2002 | 36193 | 0.000 |
Why?
|
| Brain | 1 | 2005 | 27121 | 0.000 |
Why?
|